Field Access Director, Rare Disease

Field Access Director

Ipsen Biopharmaceuticals Inc. is seeking a Field Access Director for its US Rare Disease portfolio. The Field Access Director (FAD) is a field-based, individual contributor role with primary accountability for patient access and reimbursement. The FAD serves as the central point of contact of the patient access ecosystem, coordinating across the Ipsen CARES hub, limited specialty pharmacy (SP) network, and sales layer to help remove barriers and support pull-through for appropriate patients.

This role demands deep expertise in payer policy, prior authorization, denials and appeals, billing and coding, limited distribution, and formulary dynamics across commercial, Medicare Part D, and Medicaid channels. The FAD provides education and reimbursement support to Healthcare Providers (HCPs), healthcare institutions, prior authorization staff, and financial counselors, and addresses patient-specific access challenges including affordability, prior authorization, coverage gaps, and reimbursement.

This position collaborates closely with Sales, Marketing, Value & Access, Patient Services, and Medical Affairs when appropriate, delivering exceptional customer experience and actionable field intelligence. This FAD will have regional responsibility for the Northeast region.

• Ensure access pull-through for all Ipsen Rare Disease therapies by proactively educating HCPs, office staff, and specialty pharmacy partners on coverage requirements, payer policies, prior authorization pathways, and patient out-of-pocket costs across commercial, Medicare Part D, and Medicaid channels.
• Identify and help resolve access barriers for individual patients in a timely manner, including preauthorization, step therapy, denials, appeals, and affordability challenges.
• Support processes for enrolling patients in Ipsen patient support programs; work directly with Patient Access Managers (PAMs) to resolve complex cases.
• Clearly communicate available distribution options — including the limited SP network and any site-of-care channel alternatives — to HCPs, hospitals, and Integrated Delivery Networks (IDNs).
• Monitor formulary positioning for Ipsen Rare Disease products and proactively communicate unexpected changes to Payer team.
• Develop and manage structured communication channels with key account stakeholders including providers, office staff, financial counselors, and specialty pharmacies to facilitate ongoing patient access.
• Apply account prioritization and influence mapping to identify high-impact accounts and ensure FAD time is deployed against the highest patient need.
• Engage in both in-person and virtual education with defined accounts on a wide range of access, reimbursement, billing, and coding topics relevant to Ipsen's Rare Disease portfolio.
• Serve as a primary field liaison to the Ipsen CARES Patient Support Hub; increase provider and staff awareness of hub capabilities and streamline communication channels between the FAD and PAM.
• Collaborate with specialty pharmacies and the CSS layer to ensure seamless patient onboarding, timely drug access, prescription renewals, and refill continuity.
• Utilize CRM and data portal tools (e.g., case triaging platforms, access dashboards) to monitor high-need cases, identify bottlenecks in the patient journey, and coordinate timely resolution.
• Identify stages in the patient access journey causing delays — including benefit verification, PA initiation, prior authorization, or SP fulfillment — and partner with hub and internal stakeholders to resolve proactively.
• Collaborate with payer team, providing insights or for troubleshooting unexpected payer barriers.
• Serve as the field expert on local and regional payer coverage policies, benefit design, and reimbursement trends; advise internal sales and account management teams on specific payer access challenges.
• Support strategic analysis and escalation to payer team related to changes in local payer coverage policies, including commercial formulary updates, Medicare Part D changes and their implications for Ipsen's portfolio.
• Conduct regular pulse-check engagement with accounts to monitor…